境崇行 (Takayuki Sakai) - マイポータル

基本情報

Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment.

Takayuki Sakai, Yoshiyuki Matsuo, Kensuke Okuda, Kiichi Hirota, Mieko Tsuji, Tasuku Hirayama, Hideko Nagasawa

Scientific reports 11(1) 4852-4852 2021年3月1日
Effects of 2-(2-Chlorophenyl)ethylbiguanide on ERAD Component Expression in HT-29 Cells Under a Serum- and Glucose-Deprived Condition.

Kentaro Oh-Hashi, Shiori Matsumoto, Takayuki Sakai, Yoko Hirata, Kensuke Okuda, Hideko Nagasawa

Applied biochemistry and biotechnology 188(4) 1009-1021 2019年8月査読有り
Elucidating the rapid action of 2-(2-chlorophenyl)ethylbiguanide on HT-29 cells under a serum- and glucose-deprived condition.

Kentaro Oh-Hashi, Shiori Matsumoto, Takayuki Sakai, Yuki Nomura, Kensuke Okuda, Hideko Nagasawa, Yoko Hirata

Cell biology and toxicology 34(4) 279-290 2018年8月査読有り
Elucidation of a novel phenformin derivative on glucose-deprived stress responses in HT-29 cells.

Kentaro Oh-Hashi, Nao Irie, Takayuki Sakai, Kensuke Okuda, Hideko Nagasawa, Yoko Hirata, Kazutoshi Kiuchi

Molecular and cellular biochemistry 419(1-2) 29-40 2016年8月査読有り